Epigenetic control of epithelial-mesenchymal-transition in human cancer.
about
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theoryDeregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential BiomarkersCell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity.Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone.Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor.Association of aberrant DNA methylation in Apc(min/+) mice with the epithelial-mesenchymal transition and Wnt/β-catenin pathways: genome-wide analysis using MeDIP-seqLincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancerGERD-Barrett-Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation.Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells.Integrated genomic and molecular characterization of cervical cancer.Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivoEMT: Present and future in clinical oncology.Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer.Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7.Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.Cellular analysis of the action of epigenetic drugs and probes.Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate CancerBiliary tract cancer stem cells - translational options and challenges.EMT and Treatment Resistance in Pancreatic Cancer.Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites.Novel Polyamine-Naphthalene Diimide Conjugates Targeting Histone Deacetylases and DNA for Cancer Phenotype Reprogramming.Long non-coding RNA LINC00959 predicts colorectal cancer patient prognosis and inhibits tumor progression.Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review).Asiatic acid inhibits proliferation, migration and induces apoptosis by regulating Pdcd4 via the PI3K/Akt/mTOR/p70S6K signaling pathway in human colon carcinoma cells.Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression.
P2860
Q26771988-BDB36E73-05AD-487D-BCE1-C5BFD37AF825Q26780223-10A47AE3-F11D-484A-981A-EF7AE12B2D92Q28073195-EC9459F2-BD30-4F85-95D5-3EB689E2A6ACQ33767473-76321068-9F5E-4FE0-A55F-21ECAF4C776BQ35739519-1CAFC634-EBA1-4FF5-91C7-927271FEB66FQ35742395-135A9DE8-6893-43F7-8FD9-740C94B205A7Q35765192-5727FA28-2E5D-42DC-A1D7-59E3F662C86EQ36293805-4844700C-3537-4ADB-8768-1455B97675B3Q36737638-8EC40C97-0976-4C26-8928-8F438BC6F840Q36745159-5A3532E6-AE75-46D2-930C-8F080CB6082DQ36992190-0C24A8D0-204E-447B-B96B-BACCEA91F7ECQ37399295-C4E5454D-87F2-4B4E-89C4-EC8F5981A445Q37466825-84570A24-5ECE-47EA-96CE-F66748061780Q37706407-5C6755FA-63C3-4368-A0D9-A5EC8AB4580BQ37709487-E44CB3FF-0D58-44C0-B1C7-E6D176BF4B1FQ38673790-9E4B4877-255F-41CC-99B9-C87C1F5F4DFCQ38696030-0D95B31D-BD7C-43CC-AF5B-CB89916763A3Q38733932-37EC54AC-0FF6-41B9-839C-3DA5E479E95BQ38755283-0B7D34D5-93E4-48AB-AE6F-8229D6E28CB3Q38773945-B2CE89E7-43BA-4EA9-BFAD-1E207A901340Q38789702-C247F5E0-36FC-454F-958A-76921AD5964FQ38909048-414C0C35-3943-4654-A644-BF34A194B387Q39077976-74439868-0CDF-4A9D-96F3-9E340157405FQ39152842-BD1DA497-3616-461A-BB67-D67A61CA49B1Q39279276-5DFF5818-5991-49BD-8EA8-92ABC382FC3CQ41670877-95C52D15-2DDC-4AB5-942C-92E5978F9D4DQ47107732-A3F0FF85-412F-4E21-8D04-ADF7A41067ACQ47141661-E9E2CB57-DA25-4A31-8496-6C439DC822C8Q47146557-B64C6850-E76B-472E-A3D5-5A5908E8C3C8Q49501076-562B01B0-BA21-4910-AE56-AA2FCE444AC3Q54978017-31DD74C7-FC30-4480-9089-ADB509E9842DQ55256814-E1BF5A69-237F-4130-83AA-A7727A9EA7E3
P2860
Epigenetic control of epithelial-mesenchymal-transition in human cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Epigenetic control of epithelial-mesenchymal-transition in human cancer.
@en
Epigenetic control of epithelial-mesenchymal-transition in human cancer.
@nl
type
label
Epigenetic control of epithelial-mesenchymal-transition in human cancer.
@en
Epigenetic control of epithelial-mesenchymal-transition in human cancer.
@nl
prefLabel
Epigenetic control of epithelial-mesenchymal-transition in human cancer.
@en
Epigenetic control of epithelial-mesenchymal-transition in human cancer.
@nl
P2860
P356
P1476
Epigenetic control of epithelial-mesenchymal-transition in human cancer.
@en
P2093
Daniel Neureiter
Martin Pichler
P2860
P356
10.3892/MCO.2012.28
P577
2012-09-25T00:00:00Z